The Washington University Infectious Diseases Clinical Research Unit ( ID-CRU) is known for its expertise and is well established in the community. Led by Rachel Presti, MD, PhD, the ID-CRU provides access to general Infectious Diseases research opportunities, community outreach and education. Our lead faculty in these areas are:
Andrew Atkinson, PhD
Assistant Professor of Medicine
Dr. Atkinson is a biostatistician providing project-based and ad hoc consultancy in the division. His methodological research includes developing methods for handling missing data in clinical trials and for observational data, novel clinical trial design methods, trial emulation and Bayesian modelling.
Ishmael D. Aziati, PhD
Instructor of Medicine
- Email: idaziati@wustl.edu
Dr Aziati specializes in the use of integrated approaches to control and prevent emerging vector-borne and zoonotic viral diseases, with a special focus on pathogen surveillance and developing therapeutic interventions.
Philip J. Budge, MD, PhD
Associate Professor of Medicine
- Phone: 314-747-5198
- Fax: 314-454-5392
- Email: pbudge@wustl.edu
Dr. Budge specializes in translational, public health-related research, with a special focus on filarial infections—insect-borne threadlike parasitic worms that cause lymphatic filariasis (elephantiasis), onchocerciasis (river blindness), and loiasis (African eye worm).
Michael S. Diamond, MD, PhD
The Herbert S. Gasser Professor, Departments of Medicine, Molecular Microbiology, Pathology & Immunology
- Phone: 314-362-2842
- Fax: 314-362-9230
- Email: diamond@wusm.wustl.edu
Michael Diamond, MD, PhD is the leader of a basic and translational research laboratory studying the interface between viral pathogenesis and host immunity. His laboratory focuses on emerging RNA viruses including flaviviruses, alphaviruses, and coronaviruses.
Conor Grant, MD, PhD
Assistant Professor of Medicine
- Email: conorg@wustl.edu
Dr. Grant specializes in the innate immune responses to the pathogens causing Tuberculosis (TB), Nontuberculous Mycobacterial (NTM) and COVID-19 infections, and his laboratory research includes the search for novel therapies targeting the host for these difficult infections.
Jeffrey P. Henderson, MD, PhD
Professor of Medicine and Molecular Microbiology
- Phone: 314-747-0240
- Fax: 314-362-1232
- Email: hendersonj@wustl.edu
Dr. Henderson specializes in infection pathogenesis, with a special focus on urinary tract infections and identifying how special bacterial adaptations increase pathogenic potential in patients.
Michael J. Hendrix, MD
Assistant Professor of Medicine
- Email: mhendrix@wustl.edu
Dr. Hendrix specializes in antimicrobial stewardship and clinical infectious disease with a special focus on COVID-19 and bone marrow transplant (BMT) recipients.
Jenny Hyde, PhD
Associate Professor of Medicine
- Email: j.hyde@wustl.edu
Dr. Jenny Hyde leads and performs basic research centered on virus-host interactions. Her work combines molecular virology and RNA biology to uncover the mechanisms by which viral RNA structures regulate RNA-protein interactions, with the goal of identifying new therapeutic targets and advancing antiviral and vaccine development.
Michael Klebert, PhD, RN, ANP-BC
Instructor in Medicine
- Phone: 314-454-0058
- Email: mklebert@wustl.edu
Rachel M. Presti, MD, PhD
Professor, Infectious Diseases | Medical Director of the Infectious Disease Clinical Research Unit (IDCRU)
- Phone: 314-454-8215
- Fax: 314-454-5392
- Email: prestir@wustl.edu
Dr. Presti specializes in clinical and translational research in infectious disease, with a special focus on HIV, SARS-CoV-2 and other viral infections.